How much does Stem Cell Treatment for Joint Pain cost?
At Stem Cell Mexico, stem cell treatment for joint pain typically costs $3,900 to $6,000 USD for one joint (wrist and toe joints $3,900 to $5,000 USD), $6,000 to $9,000 USD for two or more joints, and $6,000 to $8,000 USD for a joint-specific osteoarthritis plan.

Where you fall in that range depends on which joints are treated (knee, hip, shoulder, ankle, elbow, wrist or hand), the size of each joint, whether tendons, ligaments or other structures around the joint are also treated, the number of cells recommended, the type of image guidance required and whether you add an intravenous (IV) infusion. Your complete cost is confirmed in writing after a medical evaluation and before you pay a deposit, and only the items listed in your quote are included.
Joint pain is one of the most common reasons people explore regenerative medicine. This guide explains what drives the price, how treatment differs from joint to joint, what the evidence shows and how to decide whether it makes sense for you.
What the price usually includes
Every plan is personalized, but a joint treatment quote typically covers:
- Medical evaluation with the doctor and stem cell specialist, reviewing your imaging (MRI or X-rays), symptoms and previous treatments.
- Pre-treatment laboratory testing: blood count, metabolic panel, urinalysis and tumor markers.
- Allogeneic mesenchymal stromal cells (MSCs) from donated umbilical cord tissue (Wharton's jelly), prepared for your date.
- Ultrasound-guided injections into the joint and, when indicated, surrounding tendons or ligaments.
- Platelet-rich plasma (PRP) prepared from your own blood, and sedation when the protocol calls for it.
- Medical observation, ground transportation between the San Diego airport area and the clinic, and follow-up after you return home.
Flights, extra hotel nights and companion lodging are usually separate.
Why one joint and multiple joints are priced differently
Joint size and complexity
A knee or hip requires a larger dose than a wrist, finger joint or elbow. The hip is deep and requires precise guidance. The shoulder often involves several structures at once, such as the glenohumeral joint, the rotator cuff and the bursa.
Number of joints
Multiple-joint plans need more cells, more preparation and more procedure time. Because some costs (evaluation, labs, observation, transportation) are shared, treating several joints in one visit is usually more cost-efficient per joint than separate trips.
Associated injuries
Many painful joints combine osteoarthritis with tendon or ligament damage, meniscus or labrum tears, or chronic bursitis. Treating these structures can improve the chance of benefit but changes the protocol.
IV infusion
Some patients with pain in several joints choose an IV infusion to complement local injections, aiming for systemic anti-inflammatory support. This is priced separately.
How treatment differs by joint
- Knee: The most studied joint in regenerative research, especially for osteoarthritis. Injections are placed inside the joint and sometimes around the meniscus or ligaments.
- Hip: Osteoarthritis and labral tears are common targets. The joint is deep, so image guidance is essential. Results depend strongly on how much cartilage remains.
- Shoulder: Rotator cuff tendinopathy and partial tears, glenohumeral arthritis and frozen shoulder have different biology. Large full-thickness tears with retraction may still need surgical repair.
- Ankle and foot: Ankle osteoarthritis, chronic ligament instability and tendon problems such as Achilles or peroneal tendinopathy may be evaluated.
- Elbow, wrist and hand: Tennis elbow, thumb base arthritis and small-joint osteoarthritis require smaller doses and precise placement.
This variety is why we avoid a single "joint price" and instead quote based on what your evaluation shows.
How the treatment works
Mesenchymal stromal cells influence the joint through signals rather than by becoming new tissue in large amounts. Current research suggests they:
- Reduce inflammation in the synovium, the lining of the joint that becomes inflamed in osteoarthritis.
- Modulate immune activity, shifting the joint environment from a destructive state toward a more balanced one.
- Support tissue repair by releasing growth factors and extracellular vesicles that help cartilage cells, tendons and ligaments.
PRP adds the patient's own growth factors. Ultrasound guidance allows accurate placement, which matters especially in smaller or deeper joints.
What the evidence says
Established safety signal: A 2024 systematic review and meta-analysis in the Journal of Orthopaedic Translation (Tabet and colleagues) pooled 25 randomized controlled trials with more than 1,000 participants receiving MSCs for knee osteoarthritis. It found no difference in serious adverse events compared with control treatments.
Efficacy: The same analysis found greater pain reduction at 12 months versus hyaluronic acid and versus placebo, along with improvements in function. Most high-quality data come from the knee; evidence for the hip, shoulder and ankle is growing but is based on smaller studies.
Standard care context: The UK's NICE osteoarthritis guideline (NG226) emphasizes exercise, weight management, education and, when needed, short-term medications or joint replacement. Cell therapy is not yet part of routine guideline recommendations.
Regulatory perspective: The International Society for Stem Cell Research (ISSCR) encourages patients to ask detailed questions about any cell treatment, including the evidence for their specific condition, the cell source and how safety is monitored. The FDA has warned consumers that no stem cell or exosome products are approved in the United States for orthopedic conditions such as arthritis, tendonitis or back pain, and has raised concerns about unregulated products. In Mexico, cell therapies are regulated by COFEPRIS, and products must come from licensed laboratories.
What this means for you
For joint pain, especially knee osteoarthritis, regenerative therapy is supported by a reasonable safety record and encouraging, though not definitive, efficacy data. It is best suited for people looking for a minimally invasive option between conservative care and surgery, with realistic expectations of pain relief and improved function rather than a guaranteed "new joint."
How your joints are evaluated before a quote
An accurate quote depends on an accurate diagnosis. During the evaluation, the doctor reviews where the pain is, what movements trigger it, how long it has lasted and what you have already tried, such as physical therapy, cortisone or hyaluronic acid injections, or surgery. Imaging is then matched to those symptoms: X-rays show joint space narrowing and bone changes, while MRI or ultrasound shows cartilage, tendons, ligaments and soft tissue. If your MRI is older than three months or does not include the painful joint, an updated study may be recommended. The goal is to identify the main pain generator in each joint, because treating the right structures is one of the most important factors in whether regenerative treatment helps. It also prevents paying for injections in areas that are not the real source of pain.
Who may be a candidate
Good candidates usually have:
- Mild to moderate osteoarthritis, or tendon and ligament injuries that have not healed with conservative treatment.
- Pain that limits activity despite physical therapy, medications or injections.
- Recent imaging confirming the source of pain.
- Good general health, no active infection and no cancer history within the last five years.
Patients with severe bone-on-bone arthritis and deformity may still be evaluated, but should understand that the likelihood of meaningful benefit is lower and that joint replacement may remain the best long-term option.
What results patients commonly ask about
How soon will I notice changes? After a few days of soreness, many patients notice gradual improvement over six to twelve weeks, with progress continuing for several months.
How long do results last? Most studies follow patients for one to two years. Some maintain benefit longer; others use PRP boosters or a second treatment.
Can I treat all my joints at once? Often, yes, within safe limits. Your doctor may prioritize the most limiting joints first.
What can affect outcomes
- Severity of joint damage and alignment.
- Body weight and muscle strength around the joint.
- Following post-treatment instructions: rest the first days, avoid high-impact activity for about a month and start guided physical therapy around the second week.
- Avoiding anti-inflammatory drugs and supplements around the treatment period as instructed.
- Smoking, alcohol and metabolic health.
Risks and limitations
The most common effects are temporary pain, swelling and stiffness for three to seven days. Rare risks include infection, bleeding and allergic reactions. When an IV infusion is added, temporary fever or fatigue may occur. The main limitation is variable response: not every patient improves, and the size of benefit differs between joints and individuals.
Questions to ask during your evaluation
- Which structures in each joint will be treated?
- How many cells per joint, and why?
- Will injections be ultrasound-guided?
- Is it better to treat all joints now or in stages?
- What exactly is included in my quote?
Bottom line
Stem cell treatment for joint pain at Stem Cell Mexico ranges from $3,900 to $6,000 USD for one joint and $6,000 to $9,000 USD for two or more joints. Evidence is strongest for the knee and growing for other joints, with a favorable safety profile. A medical evaluation can help determine whether this type of regenerative treatment is appropriate for your joints, goals and medical history, and gives you a written quote before you commit.
References
- Tabet CG et al. Advanced therapy with mesenchymal stromal cells for knee osteoarthritis: systematic review and meta-analysis of randomized controlled trials. Journal of Orthopaedic Translation, 2024 (opens in a new tab)
- NICE guideline NG226: Osteoarthritis in over 16s, diagnosis and management (opens in a new tab)
- International Society for Stem Cell Research (ISSCR): The ISSCR Guide to Stem Cell Treatments (opens in a new tab)
- U.S. Food and Drug Administration (FDA): Consumer alert on regenerative medicine products including stem cells and exosomes (opens in a new tab)
